INTS · Intensity Therapeutics, Inc. · Fails to Deliver
$3.07
-0.01 (-0.32%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As of September 30, 2026, our cash and cash equivalents were approximately $8.5 million. Based on our balances in cash and cash equivalents, our ability to continue our operations is dependent on obtaining additional capital, which is not within our control. As a result, we believe there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$10.13M
Shares
3.30M
Volume · Nov 16
4555
Avg daily vol (3M)
22.42K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 32 | $3.25 | $104 |
| 2026-10-14 | 3,584 | $3.55 | $12,723 |
| 2026-10-08 | 14 | $3.80 | $53 |
| 2026-10-05 | 402 | $3.44 | $1,383 |
| 2026-09-15 | 201 | $3.98 | $800 |
| 2026-09-14 | 825 | $4.02 | $3,317 |
| 2026-09-09 | 201 | $4.09 | $822 |
| 2026-09-03 | 500 | $4.00 | $2,000 |
| 2026-08-31 | 6,040 | $4.25 | $25,670 |
| 2026-08-28 | 9,372 | $4.27 | $40,018 |
| 2026-08-27 | 470 | $4.53 | $2,129 |
| 2026-08-26 | 632 | $4.90 | $3,097 |
| 2026-08-21 | 3,954 | $4.88 | $19,296 |
Showing 1–13 of 13 settlements
Key facts
CIK
1567264
CUSIP
45828J202
13F (30d)
14 filings
14 filers
Visit website
Investor relations